Skip to main content

Solésence Inc. Value Stock - Dividend - Research Selection

Nanophase technologies

ISIN: US6300791018 , WKN: 910885

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Nanophase Technologies Corporation develops and manufactures advanced materials and applications with an integrated nanomaterial and related technologies. It produces engineered nano and larger, and sub-micron materials for use in various markets, which comprise personal care, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy, and various surface finishing technologies. The company was founded in 1989 and is headquartered in Romeoville, Illinois.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Solesence: Expect Operational Challenges In The Coming Quarters

2025-11-20
Solesence, Inc. faces financial challenges, margin compression, and slowing revenue growth. Click here to read why SLSN stock is a Strong Sell.

Solesence Inc (SLSN) Q3 2025 Earnings Call Highlights: Navigating Challenges and Leveraging ...

2025-11-11
Solesence Inc (SLSN) faces revenue and margin pressures but remains optimistic about future growth through strategic reorganization and innovation.

Solesence (SLSN) Q3 2025 Earnings Call Transcript

2025-11-11
Kevin Carrington: Thank you, operator. Today is a meaningful moment in the history of Solesence, Inc. Common Stock. Today marks Jess Jankowski's final earnings call as a member of the Solesence leadership team.

Solésence Reports Third Quarter 2025 Financial Results

2025-11-11
Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025. Recent Highlights and Accomplishments Continued strategic transformation to drive future innovation and growth with promotio

Solesence, Inc. (SLSN) Q3 2025 Earnings Call Transcript

2025-11-11

Discovering US Market's Hidden Gems with 3 Promising Small Caps

2025-11-10
Amidst a backdrop of optimism for a resolution to the U.S. government shutdown, major stock indices have seen gains, with the tech-heavy Nasdaq and S&P 500 bouncing back from recent declines. In this environment, identifying promising small-cap stocks can be particularly rewarding as they often thrive on market recoveries and investor sentiment shifts; these companies can offer unique growth opportunities when larger caps are under pressure.

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

2025-11-10
Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoana Dvorzsak to the newly created role of Vice President of Innovation and Product Integrity to support the Compan

Discover 3 Undiscovered Gems In The US Market

2025-11-10
In the midst of a challenging period for U.S. markets, with major indices like the Nasdaq experiencing significant declines due to tech sector pressures and economic uncertainties from a prolonged government shutdown, investors are increasingly looking beyond the usual suspects in search of opportunities. In this environment, identifying promising stocks often involves finding companies that demonstrate resilience and potential for growth despite broader market volatility.

Undiscovered Gems in the US Market to Explore This November 2025

2025-11-07
The U.S. stock market has recently faced turbulence, with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average closing lower amid renewed concerns over AI valuations and significant job cuts reported in October. As investors navigate these uncertain times, identifying promising small-cap stocks—often overlooked yet full of potential—can be a strategic approach to uncovering value in a volatile market environment.

Undiscovered Gems in the US Market for November 2025

2025-11-03
As the U.S. stock market wraps up October 2025 with impressive gains across major indices, including a notable rise in the Nasdaq driven by strong tech performances, investors are turning their attention to small-cap stocks that might have been overlooked amidst the broader rally. In such a dynamic environment, identifying potential gems requires looking beyond headline-grabbing giants and focusing on companies with robust fundamentals and unique growth opportunities that align well with...